Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in Billions.
The item "Diluted-Average-Shares" stands at 6.58 Billion for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.
Chugai Pharmaceutical Co. Ltd.'s second quarter result of 1.65 Billion for the item "Diluted Average Shares" represents a decrease of -0.01 percent compared to it's first quarter result.
Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of 1.65 Billion for the item "Diluted Average Shares" represents an increase of 0 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of 6.58 Billion for the item "Diluted Average Shares" represents an increase of 6E-4 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.0195 percent compared to the value the year prior.
The 1 year change in percent is 0.0195.
The 3 year change in percent is 0.0358.
The 5 year change in percent is 0.1062.
The 10 year change in percent is 0.4212.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Diluted Average Shares | 905,699,262,464.00 |
![]() | Johnson & Johnson - Diluted Average Shares | 486,508,953,600.00 |
![]() | AbbVie Inc - Diluted Average Shares | 399,570,305,024.00 |
![]() | Roche Holding AG - Diluted Average Shares | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Diluted Average Shares | 280,205,508,085.11 |